Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Reduces Stock Position in The Chemours Company (NYSE:CC)

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA trimmed its holdings in shares of The Chemours Company (NYSE:CCFree Report) by 5.3% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 8,162 shares of the specialty chemicals company’s stock after selling 460 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in Chemours were worth $246,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the company. Legacy Financial Group LLC bought a new stake in shares of Chemours in the third quarter worth about $29,000. Morton Brown Family Wealth LLC purchased a new position in shares of Chemours in the fourth quarter worth about $35,000. Anchor Investment Management LLC purchased a new stake in shares of Chemours in the 4th quarter valued at $56,000. Geneos Wealth Management Inc. grew its position in Chemours by 116.4% during the 4th quarter. Geneos Wealth Management Inc. now owns 1,859 shares of the specialty chemicals company’s stock worth $59,000 after purchasing an additional 1,000 shares during the period. Finally, IFP Advisors Inc lifted its holdings in Chemours by 39.0% in the third quarter. IFP Advisors Inc now owns 2,232 shares of the specialty chemicals company’s stock valued at $63,000 after acquiring an additional 626 shares during the period. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

Chemours Stock Up 1.7 %

CC stock traded up $0.44 during trading on Tuesday, hitting $26.87. 480,316 shares of the company’s stock were exchanged, compared to its average volume of 1,864,352. The Chemours Company has a 52-week low of $15.10 and a 52-week high of $39.05. The company has a debt-to-equity ratio of 5.40, a current ratio of 1.54 and a quick ratio of 1.00. The business has a 50-day moving average price of $26.80 and a two-hundred day moving average price of $27.80.

Chemours (NYSE:CCGet Free Report) last announced its quarterly earnings results on Wednesday, March 27th. The specialty chemicals company reported $0.31 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.02. The firm had revenue of $1.36 billion during the quarter, compared to analysts’ expectations of $1.37 billion. Chemours had a negative net margin of 3.80% and a positive return on equity of 51.73%. As a group, equities research analysts expect that The Chemours Company will post 2.23 EPS for the current fiscal year.

Chemours Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Monday, February 26th were given a $0.25 dividend. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $1.00 annualized dividend and a yield of 3.72%. Chemours’s dividend payout ratio (DPR) is -64.52%.

Analyst Ratings Changes

CC has been the subject of several recent analyst reports. BMO Capital Markets upgraded shares of Chemours from an “underperform” rating to an “outperform” rating and upped their price objective for the stock from $19.00 to $34.00 in a research report on Tuesday, April 9th. UBS Group boosted their price target on shares of Chemours from $21.00 to $28.00 and gave the company a “neutral” rating in a research note on Tuesday, April 2nd. Finally, Barclays cut their price target on shares of Chemours from $32.00 to $30.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 2nd. Seven investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $30.89.

View Our Latest Stock Report on Chemours

Chemours Profile

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

See Also

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCFree Report).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.